Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACHL | AZN | AMGN | GILD | GSK |
| Company | Achilles Therapeutics Plc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.4800 | 208.75 | 377.91 | 152.34 | 60.93 |
| High | 1.5000 | 208.95 | 379.93 | 152.82 | 61.06 |
| Low | 1.4450 | 205.72 | 374.13 | 150.33 | 59.98 |
| Latest | 1.4800 | 208.62 | 375.50 | 151.12 | 60.85 |
| Change | +0.0100 | -0.05 | -4.23 | -1.62 | -0.33 |
| % Change | +0.68% | -0.02% | -1.11% | -1.06% | -0.54% |
| Volume | 1,204,100 | 2,037,100 | 2,427,100 | 7,357,900 | 4,868,300 |
| 20-Day Average Volume | 1,689,445 | 2,981,065 | 3,027,305 | 8,497,189 | 6,603,575 |
| Previous Close | 1.4700 | 208.67 | 379.73 | 152.74 | 61.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4047 | 193.47 | 359.62 | 146.10 | 55.52 |
| 20-Day Raw Stochastic | 80.00% | 87.36% | 79.55% | 78.19% | 93.79% |
| 20-Day Relative Strength | 74.12 | 66.78 | 62.64 | 63.57 | 74.49 |
| Weighted Alpha | +34.26 | +50.57 | +32.75 | +47.62 | +79.36 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 64% Buy | 80% Buy | 72% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.23% since 03/13/25 | +1.89% since 02/11/26 | +2.43% since 02/11/26 | -3.00% since 02/11/26 | +4.03% since 02/11/26 |
| Low | 1.4000 on 03/14/25 | 202.10 on 02/12/26 | 361.71 on 02/13/26 | 150.33 on 02/19/26 | 58.05 on 02/12/26 |
| High | 1.5100 on 03/19/25 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +6.47% since 02/20/25 | +10.51% since 01/16/26 | +13.65% since 01/16/26 | +20.98% since 01/16/26 | +26.19% since 01/16/26 |
| Low | 1.3600 on 03/04/25 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 47.62 on 01/20/26 |
| High | 1.5100 on 03/19/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +50.85% since 12/20/24 | +17.22% since 11/19/25 | +9.67% since 11/19/25 | +18.00% since 11/19/25 | +31.31% since 11/19/25 |
| Low | 0.9601 on 12/24/24 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.81 on 11/20/25 |
| High | 1.5100 on 03/19/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +42.31% since 09/20/24 | +31.14% since 08/19/25 | +27.05% since 08/19/25 | +28.09% since 08/19/25 | +53.58% since 08/19/25 |
| Low | 0.9200 on 09/25/24 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 1.5100 on 03/19/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 60,828 | 323,627,968 | 204,700,304 | 189,501,472 | 124,709,680 |
| Shares Outstanding, K | 41,100 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -69,670,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -19,600,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 1.25 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/14/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 06/04/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.86 | 17.09 | 19.05 | 13.47 |